[go: up one dir, main page]

NO20080068L - Topisk unguale formuleringer - Google Patents

Topisk unguale formuleringer

Info

Publication number
NO20080068L
NO20080068L NO20080068A NO20080068A NO20080068L NO 20080068 L NO20080068 L NO 20080068L NO 20080068 A NO20080068 A NO 20080068A NO 20080068 A NO20080068 A NO 20080068A NO 20080068 L NO20080068 L NO 20080068L
Authority
NO
Norway
Prior art keywords
ungual
topical
formulations
nail
permeability
Prior art date
Application number
NO20080068A
Other languages
English (en)
Inventor
Robert Turner
Marc Barry Brown
Stuart Allen Jones
Original Assignee
Medpharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medpharm Ltd filed Critical Medpharm Ltd
Publication of NO20080068L publication Critical patent/NO20080068L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/40Peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Påføring av et reduksjonsmiddel fulgt av et oksidasjonsmiddel på en negl gir en vesentlig økning av neglens permeabilitet, hvorved passasje av medikamenter gjennom neglen tillates.
NO20080068A 2005-06-06 2008-01-04 Topisk unguale formuleringer NO20080068L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0511499.6A GB0511499D0 (en) 2005-06-06 2005-06-06 Topical ungual formulations
PCT/GB2006/002064 WO2006131721A2 (en) 2005-06-06 2006-06-06 Topical ungual formulations

Publications (1)

Publication Number Publication Date
NO20080068L true NO20080068L (no) 2008-03-05

Family

ID=34835209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080068A NO20080068L (no) 2005-06-06 2008-01-04 Topisk unguale formuleringer

Country Status (16)

Country Link
US (1) US20080207537A1 (no)
EP (1) EP1888029A2 (no)
JP (1) JP2008542349A (no)
KR (1) KR20080027765A (no)
CN (1) CN101203209A (no)
AU (1) AU2006256593A1 (no)
BR (1) BRPI0611115A2 (no)
CA (1) CA2610605A1 (no)
GB (1) GB0511499D0 (no)
IL (1) IL187893A0 (no)
MX (1) MX2007015424A (no)
NO (1) NO20080068L (no)
NZ (1) NZ563844A (no)
RU (1) RU2408361C2 (no)
WO (1) WO2006131721A2 (no)
ZA (1) ZA200710541B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8333981B2 (en) * 2007-10-09 2012-12-18 Humco Holding Group, Inc. Antifungal treatment of nails
US9320921B2 (en) * 2008-12-22 2016-04-26 Karen C. Swenholt Nail fungus treatment and composition
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
EP2547323B1 (en) 2010-03-17 2016-01-27 Novaliq GmbH Pharmaceutical composition for treatment of increased intraocular pressure
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
MX335945B (es) * 2011-02-11 2016-01-04 Moberg Pharma Ab Composicion antifungica novedosa.
ES2665986T3 (es) * 2011-05-11 2018-04-30 Veloce Biopharma Llc Composiciones antifúngicas para el tratamiento de las uñas
PT2714010T (pt) * 2011-05-25 2017-05-05 Novaliq Gmbh Composição farmacêutica tópica à base de alcanos semifluorados
CN103561724B (zh) * 2011-05-25 2016-06-29 诺瓦利克有限责任公司 给药给甲的药物组合物
JP6084987B2 (ja) 2012-01-23 2017-02-22 ノバリック ゲーエムベーハー セミフッ素化アルカンに基づく安定化タンパク質組成物
EP3488847B1 (en) 2012-09-12 2023-11-08 Novaliq GmbH Semifluorinated alkane compositions
DE202013012742U1 (de) 2012-09-12 2019-01-22 Novaliq Gmbh Zusammensetzungen umfassend Mischungen aus semifluorierten Alkanen
ES2687094T3 (es) 2013-07-23 2018-10-23 Novaliq Gmbh Composiciones estabilizadas de anticuerpos
ITUB20153759A1 (it) 2015-09-21 2017-03-21 Federica Livieri Composizione antifungina ad uso topico per il trattamento dell'onicomicosi e relativo metodo
PT3355990T (pt) 2015-09-30 2019-09-11 Novaliq Gmbh Compostos semifluorados e as suas composições
PT3356313T (pt) 2015-09-30 2020-07-13 Novaliq Gmbh 2-perfluoro-hexiloctano para administração oftálmica
PL3442480T3 (pl) 2016-06-23 2020-04-30 Novaliq Gmbh Sposób podawania miejscowego
CA3036297C (en) 2016-09-22 2023-09-05 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
WO2018055101A1 (en) 2016-09-23 2018-03-29 Novaliq Gmbh Ophthalmic compositions comprising ciclosporin
ES2957559T3 (es) 2017-04-21 2024-01-22 Dermaliq Therapeutics Inc Composiciones de yodo
WO2018206656A1 (en) 2017-05-12 2018-11-15 Novaliq Gmbh Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions
IL273531B2 (en) 2017-09-27 2024-05-01 Novaliq Gmbh Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
CN111182893A (zh) 2017-10-04 2020-05-19 诺瓦利克有限责任公司 包含f6h8的眼用组合物
MX2020009132A (es) 2018-03-02 2020-12-11 Novaliq Gmbh Composiciones farmaceuticas que comprenden nebivolol.
RU2688658C1 (ru) * 2018-04-10 2019-05-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Противогрибковый полусинтетический полиеновый антибиотик, его водорастворимые соли и фармацевтические композиции на их основе
JP2021522219A (ja) 2018-04-27 2021-08-30 ノバリック ゲーエムベーハー 緑内障の治療のためのタフルプロストを含む眼科用組成物
US11510855B2 (en) 2018-09-27 2022-11-29 Dermaliq Therapeutics, Inc. Topical sunscreen formulation
BR112021005350A8 (pt) 2018-09-27 2023-03-21 Novaliq Gmbh Reparo de barreira lipídica
CA3112031A1 (en) 2018-10-12 2020-04-16 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
KR20210118571A (ko) * 2020-03-23 2021-10-01 제이씨코리아 주식회사 감압 점착제 조성물, 이를 포함하는 점착제, 상기 점착제를 포함하는 인조네일 및 네일용 스티커

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL95393A0 (en) * 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
IL97012A0 (en) * 1990-01-30 1992-03-29 Gist Brocades Nv Topical preparations for treating human nails
DE4337945A1 (de) * 1993-11-06 1995-05-11 Labtec Gmbh Pflaster zur Behandlung von Nagelmykosen
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
FR2767686B1 (fr) * 1997-09-01 2004-12-17 Oreal Composition pour la teinture d'oxydation des fibres keratiniques comprenant du 2-chloro 6-methyl 3-aminophenol et deux bases d'oxydation, et procede de teinture
US6231840B1 (en) * 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
WO1999049895A2 (en) * 1998-03-31 1999-10-07 Johnson And Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
US20030007939A1 (en) * 1998-07-31 2003-01-09 Howard Murad Pharmaceutical compositions and methods for managing dermatological conditions
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6664292B2 (en) * 2001-06-04 2003-12-16 Mark H. Bogart Methods for the treatment of nail fungus and other microbial and mycotic conditions and compositions useful therefor
US6846837B2 (en) * 2002-06-21 2005-01-25 Howard I. Maibach Topical administration of basic antifungal compositions to treat fungal infections of the nails

Also Published As

Publication number Publication date
ZA200710541B (en) 2009-05-27
KR20080027765A (ko) 2008-03-28
US20080207537A1 (en) 2008-08-28
GB0511499D0 (en) 2005-07-13
RU2007148974A (ru) 2009-07-20
WO2006131721A3 (en) 2007-09-07
CA2610605A1 (en) 2006-12-14
JP2008542349A (ja) 2008-11-27
CN101203209A (zh) 2008-06-18
EP1888029A2 (en) 2008-02-20
RU2408361C2 (ru) 2011-01-10
MX2007015424A (es) 2008-04-17
WO2006131721A2 (en) 2006-12-14
AU2006256593A1 (en) 2006-12-14
IL187893A0 (en) 2008-03-20
NZ563844A (en) 2011-01-28
BRPI0611115A2 (pt) 2010-08-10

Similar Documents

Publication Publication Date Title
NO20080068L (no) Topisk unguale formuleringer
NO20083630L (no) Nye pyridinderivater
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
CL2009000393A1 (es) Composición farmaceutica que comprende a) un agente farmaceutico activable, b) un agente activo plasmonico; util para el tratamiento de trastornos de proliferación celular.
NO20091395L (no) Nye tiofenderivater
DE602007010664D1 (de) P53 aktivierende benzoylharnstoff- und benzoylthioharnstoff-verbindungen
MY158428A (en) Topical composition for the treatment of actinic keratosis
NO20091299L (no) Substituerte sulfonamidderivater
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
EA201170703A1 (ru) Производные адамантилбензамида
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
NO20090305L (no) Cyklosporin formuleringer
MA28707B1 (fr) Utilisation de 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines substituees lors du traitement de nausees et de vomissements
ATE510822T1 (de) Kaliumkanalinhibitoren
EA201070689A1 (ru) Композиция для личного ухода
DE602007014036D1 (de) 12-aryl-prostaglandin-analoga
DE502006005053D1 (de) Spritzbare akustikmassen
BRPI0716643A2 (pt) amidas terapêuticas e compostos relacionados
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
ATE524167T1 (de) Transdermales pflaster
TR200902923T2 (tr) Megestrol maddenin farmasötik olarak kararlı bir süspansiyonu.
ITMI20040954A1 (it) Derivati del 3,6-diazabiciclo 3.1.i.eptano ad attivita' analgesica
FR2915899B1 (fr) Nouvelles utilisations de l'hibiscus, notamment pharmaceutiques.
NO20091386L (no) Fenyloksyanilinderivater
ATE537816T1 (de) Leflunomid enthaltende pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application